Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia

Atherosclerosis

Volumn 83, Issue 2-3, 1990, Pages 101-109

  Croft, Kevin D ^a   Beilin, Lawrence J ^a   Vandongen, Robert ^a   Rouse, Ian ^a   Masarei, John ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Atherogenesis; Eicosanoid; Hypercholesterolaemia; Leukocyte; Platelet; Platelet activating factor

Indexed keywords

ICOSAPENTAENOIC ACID; SEROTONIN; THROMBOXANE B2;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPERCHOLESTEROLEMIA; LEUKOCYTE; PRIORITY JOURNAL; THROMBOCYTE;

ADENOSINE DIPHOSPHATE; ADULT; ARACHIDONIC ACID; ARACHIDONIC ACIDS; BLOOD PLATELETS; CALCIMYCIN; COLLAGEN; FATTY ACIDS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA, FAMILIAL; LEUKOTRIENE B4; LIPIDS; LUMINESCENCE; MALE; NEUTROPHILS; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; SEROTONIN; SUPPORT, NON-U.S. GOV'T; THROMBOXANE B2;

EID: 0025325318     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(90)90155-C     Document Type: Article

References (47)

1. The pathogenesis of atherosclerosis - an update
2. Eicasanoids and the blood vessel wall
3. Regulatory mechanisms in prostacyclinblood vessel interactions
4. Clinical implications of prostaglandin and thromboxane formation
5. Perspectives in platelets activating factor research
6. The pathogenesis of atherosclerosis: atherogenesis and inflammation
7. Platelet activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage
8. Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine
9. Platelet formation in hyperlipoproteinaemia
10. 2 formation in type II hyperlilipoproteinaemic patients
11. Thrombin binding and response in platelets from patients with dyslipoproteinaemias: increased stimulus response coupling in type II hyperlipoproteinaemia
12. 2 is increased in type IIA hypercholesterolaemic subjects
13. Differential effect of platelet inhibitors in normal and hypercholesterolaemic subjects
14. Platelet activation by plasma lipoproteins
15. Thrombin receptors define responsiveness of cholesterol modified platelets
16. 2 by platelets in vitro
17. Dietary cholesterol-induced changes in macrophage characteristics. Relationship to atherosclerosis
18. Studies on the pathogenesis of atherosclerosis. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolaemic rats
19. Stimulated arachidonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein
20. Increased production of lipoxygenase products by cholesterol-rich mouse macrophages
21. Stimulation of the scavenger receptor on monocytemacrophages evokes release of arachidonic acid metabolites and reduced oxygen species
22. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol
23. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
24. Simplified determination of serotonin in plasma by liquid chromatography with electrochemical detection
25. Validation of the direct radioimmunoassay of prostanoids in serum and kidney
26. Separation of leukocytes from blood and bone marrow
27. Chemiluminescence of whole blood. A simple and rapid method for the estimation of phagocytic function of granulocytes and opsonic activity in whole blood
28. Increased chemiluminescence of polymorphonuclear leukocytes from patients with progressive systemic sclerosis
29. Dietary fish oils reduce plasma levels of platelet-activating factor precursor (Lyso-PAF) in rats
30. Effect of dietary fish oils on the formation of leukotriene 134 and B5, thromboxane and platelet activating factor by rat leukocytes
31. The intracellular retention of newly synthesized platelet-activating factor
32. Influence of plasma lipoproteins on platelet aggregation in a normal male population
33. Thromboxane and vascular smooth muscle cell growth in genetically hypertensive rats
34. Platelets, platelet-derived growth factor and arteriosclerosis
35. Platelet activating factor: a biologically active phosphoglyceride
36. The role of lipoproteins in the degradation of platelet activating factor
37. Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats
38. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis
39. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic
40. Low density lipoprotein undergoes oxidative modification in vivo
41. Lipid mediators, neutrophils and endothelial injury
42. Phosphatidylinositol (PI) and PI-associated arachidonate are elevated in platelet total membranes of type IIA hypercholesterol aemic subjects
43. Fatty acid composition of serum lipids predicts myocardial infarction
44. Linoleic and eicosapentaenoic acids in adipoase tissue and platelets and risk of coronary heart disease
45. Low-density lipoproteins inhibit endothelium dependent relaxation in rabbit aorta
46. Impaired endothelium-dependent relaxation to aggregation platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolaemia and atherosclerosis
47. Effect of membrane cholesterol on phospholipid metabolism in thrombin stimulated platelets. Enhanced activation of platelet phospholipase(s) for liberation of arachidonic acid